Andrea Bortolato is an accomplished professional in the field of drug discovery, currently serving as Vice President at SandboxAQ since October 2022. Previous experience includes roles as Associate Director and Senior Principal Scientist at Bristol Myers Squibb from January 2020 to October 2022, as well as Principal Scientist at Schrödinger from December 2016 to December 2019. Prior to these positions, Andrea was a Principal Scientist and Senior Computational Chemist at Sosei Heptares between October 2010 and December 2016. Other notable experience includes co-founding AppMinded Ltd in January 2014, working as a Computational Chemist at Syngenta Crop Protection from June 2009 to September 2010, and completing a postdoctoral fellowship at Mount Sinai School of Medicine from January 2008 to May 2009, specializing in GPCR loop prediction techniques. Educational credentials include a Master of Science in Pharmacy and Medicinal Chemistry from Università degli Studi di Padova, and PhDs in Computational Chemistry from both Università degli Studi di Padova and the University of Geneva.